Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Medtronic plc, a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has pioneered advancements in medical devices, particularly in the fields of cardiac, diabetes, and neurological care.
Medtronic's core offerings include innovative products such as insulin pumps, pacemakers, and spinal implants, distinguished by their precision and reliability. The company is renowned for its commitment to improving patient outcomes and has achieved significant milestones, including the development of the first commercially available cardiac pacemaker.
With a strong market position, Medtronic continues to set industry standards, making it a trusted name in the medical, precision, and optical instruments sector. Its dedication to research and development ensures that it remains at the forefront of medical innovation.
47
DitchCarbon score
+15 vs industry average
Medtronic’s score of 47 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Medtronic?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Medtronic's reported carbon emissions
Medtronic, a US-headquartered company in the Medical, precision and optical instruments, watches and clocks industry, reported its most recent Scope 1, 2, and 3 emissions for 2025.
In 2025, Medtronic's Scope 1 emissions were 174,000,000 kg CO2e, and Scope 2 emissions were 79,000,000 kg CO2e. Their Scope 3 emissions for the same year totalled 5,265,000,000 kg CO2e. Key categories contributing to Scope 3 emissions included purchased goods and services (3,651,000,000 kg CO2e), upstream transportation and distribution (461,000,000 kg CO2e), and end-of-life treatment of sold products (302,000,000 kg CO2e).
For 2024, Medtronic reported Scope 3 emissions of 866,000,000 kg CO2e.
Looking back, Medtronic's Scope 1 and 2 emissions have shown some fluctuations. In 2023, they reported 131,500,000 kg CO2e for Scope 1 and 125,200,000 kg CO2e for Scope 2. In 2022, Scope 1 emissions were 133,500,000 kg CO2e and Scope 2 emissions were 165,700,000 kg CO2e. This followed 2021 figures of 148,800,000 kg CO2e for Scope 1 and 206,900,000 kg CO2e for Scope 2. In 2020, Scope 1 emissions were 156,000,000 kg CO2e and Scope 2 were 233,000,000 kg CO2e. Further back, in 2019, Scope 1 emissions were about 62,900,000 kg CO2e and Scope 2 were about 225,800,000 kg CO2e.
Medtronic PLC is committed to ambitious climate targets. The company aims for carbon neutrality in its operations by fiscal year 2030, with a target to reduce greenhouse gas emissions by 50% by fiscal year 2025. Medtronic PLC also commits to reducing absolute Scope 1 and 2 GHG emissions by 52% by FY2030 from a FY2020 base year. This target is classified as consistent with reductions required to keep warming to 1.5°C by the Science Based Targets initiative (SBTi). Additionally, Medtronic PLC aims to increase active annual sourcing of renewable electricity from 1.29% in FY2020 to 100% by FY2030. For its supply chain, Medtronic PLC commits that 75% of its suppliers, by emissions covering purchased goods and services and capital goods, will have science-based targets by FY2030. Furthermore, Medtronic PLC commits to reduce absolute Scope 3 GHG emissions from upstream transportation and distribution, business travel, and end-of-life treatment of sold products by 37.5% by FY2034 from a FY2024 base year. Medtronic PLC is a "BA1.5 member" of the SBTi, indicating its commitment to the Business Ambition for 1.5°C.
Assessing Medtronic as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Medtronic and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Medtronic’s Climate Goals (2030 & 2050)
3 goals2030
52% reduction in Scope 2
Medtronic PLC commits to reduce absolute scope 1 and 2 GHG emissions 52% by FY2030 from a FY2020 base year.
On track52%
2030
52% reduction in Scope 1
Medtronic PLC commits to reduce absolute scope 1 and 2 GHG emissions 52% by FY2030 from a FY2020 base year.
Behind target52%
2034
37.5% reduction in scope 3 total
Medtronic PLC commits to reduce absolute scope 3 GHG emissions from upstream transportation and distribution, business travel and end-of-lif…
Insufficient data37.5%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
12 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
FY2034 targetSee details
Active
Carbon Disclosure Project
2026 disclosureSee details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Medtronic1 year ago
47
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Medtronic’s sustainability data and climate commitments
In 2025, Medtronic reported total carbon emissions of approximately 5.5 billion kg CO2e. The largest portion, roughly 97%, stems from Scope 3 emissions, which totalled around 5.3 billion kg CO2e. Scope 1 emissions were approximately 174 million kg CO2e, and Scope 2 emissions were about 79 million kg CO2e. This breakdown highlights the significant impact of Medtronic's value chain, particularly purchased goods and services, on its overall carbon footprint.
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more